Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

trimethoprim 80mg,sulphamethoxazole 400mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

vit a 1000 iu, vit b1-1.5mg, vit b12 -2.5mg, vit c- 40mg, vit d-200iu, riboflavine 1.5mg, nicotinamide- 10mg/5ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

khandaker pharmaceuticals (unani) - habb-e ambar momiyaee - capsule

Bangladesh - English - DGDA (Directorate General of Drug Administration)

khandaker pharmaceuticals (unani) - habb-e nishat - capsule

Bangladesh - English - DGDA (Directorate General of Drug Administration)

khandaker pharmaceuticals (unani) - qurs pechish - capsule

Bangladesh - English - DGDA (Directorate General of Drug Administration)

khandaker pharmaceuticals (unani) - arq nankha - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

khandaker pharmaceuticals (unani) - sharbat jinsin - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

khandaker pharmaceuticals (unani) - sharbat kirmin - liquid

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - valganciclovir hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - entecavir, quantity: 0.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - entecavir is indicated for the treatment of chronic hepatitis b virus infection in adults 16 years or older with evidence of active liver inflammation.,this indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with hbeag-positive or hbeag-negative chronic hbv infection with compensated liver disease